CARMELL CORP (CTCX) Stock Price & Overview
NASDAQ:CTCX • US1429221039
Current stock price
The current stock price of CTCX is 0.1973 USD. Today CTCX is up by 1.39%. In the past month the price decreased by -41.64%. In the past year, price decreased by -93.31%.
CTCX Key Statistics
- Market Cap
- 5.943M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.91
- Dividend Yield
- N/A
CTCX Stock Performance
CTCX Stock Chart
CTCX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CTCX. When comparing the yearly performance of all stocks, CTCX is a bad performer in the overall market: 97.27% of all stocks are doing better.
CTCX Earnings
CTCX Forecast & Estimates
CTCX Groups
Sector & Classification
CTCX Financial Highlights
Over the last trailing twelve months CTCX reported a non-GAAP Earnings per Share(EPS) of -1.91. The EPS decreased by -335.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1047.34% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CTCX Ownership
CTCX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 364.65B | ||
| AMGN | AMGEN INC | 15.24 | 188.631B | ||
| GILD | GILEAD SCIENCES INC | 15.52 | 175.177B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.42 | 116.358B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.68 | 77.963B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 41.84 | 41.258B | ||
| INSM | INSMED INC | N/A | 31.039B | ||
| NTRA | NATERA INC | N/A | 28.733B | ||
| BIIB | BIOGEN INC | 11.29 | 26.917B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.55 | 23.098B | ||
| MRNA | MODERNA INC | N/A | 20.683B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 19.837B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.676B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CTCX
Company Profile
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasmabased bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 9 full-time employees. The company went IPO on 2021-07-29. The firm utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The firm has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The firm is also developing a line of men’s products and a line of topical haircare products.
Company Info
IPO: 2021-07-29
CARMELL CORP
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 9
Phone: 14128948248
CARMELL CORP / CTCX FAQ
What does CARMELL CORP do?
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasmabased bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 9 full-time employees. The company went IPO on 2021-07-29. The firm utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The firm has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The firm is also developing a line of men’s products and a line of topical haircare products.
What is the current price of CTCX stock?
The current stock price of CTCX is 0.1973 USD. The price increased by 1.39% in the last trading session.
Does CARMELL CORP pay dividends?
CTCX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CTCX stock?
CTCX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the employee count for CTCX stock?
CARMELL CORP (CTCX) currently has 9 employees.
Can you provide the market cap for CARMELL CORP?
CARMELL CORP (CTCX) has a market capitalization of 5.94M USD. This makes CTCX a Nano Cap stock.